Episode
A conversation with Courtney Leonard, COO of MashupMD
We speak with Miss Leonard, Chief Operating Officer of MashupMD, a healthcare news aggregation site designed to improve the experience ...
A conversation with Dr. Catherine London, opioid policy expert and a true fighter
There are victims and then there are leaders. Dr. London was supposed to be the former, but she has become ...
A conversation with Dr. Ofri, editor in chief of Bellevue Literary Review
A conversation with Dr. Ofri, editor in chief of Bellevue Literary Review We interview Dr. Danielle Ofri, a pioneer in ...
A conversation with Dr. Cifu, author of Ending Medical Reversal
We discuss Dr. Cifu's book, Ending Medical Reversal, which discusses why we enact healthcare policies based on weak evidence or ...
A conversation with TameraLynn Stewart, patient advocate turned lawmaker
We interview TameraLynn Stewart, one of the most successful chronic pain advocates in the country, who turned her experiences with ...
A conversation with Dr. Hochman, CEO of Healthcare in Action
Dr. Hochman leads a new initiative that provides healthcare services to people experiencing homelessness (PEH). The initiative is part of ...
A conversation with Dr. Chin, Professor of Healthcare Ethics and a member of the National Academy of Medicine
Dr. Chin wrote an article in the New England Journal of Medicine discussing lessons learned from COVID-19 that can apply ...
A conversation with David Poses, author of The Weight of Air and national subject matter expert in harm reduction
We interview the incomparable David Poses, renowned expert in harm reduction and author of the best-selling memoir, The Weight of ...
A conversation with Dr. Terri Lewis, thought leader for opioid policy reform
There are many prominent researchers working behind the scenes to rectify erroneous opioid policies at the state and federal level. ...
A conversation with Dr. Mark Ibsen, a hero to his patients
Dr. Ibsen has experienced tremendous highs and lows in his career as a rural primary care physician. But above all ...
A conversation with Dr. John Whyte
We interview John Whyte, MD, MPH, a popular physician and writer who has been communicating to the public about health ...
A conversation with Dr. Pringl Miller
Dr. Miller is a board-certified general surgeon and hospice & palliative medicine specialist with additional fellowship training in clinical medical ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more